| Product Code: ETC6209263 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Parkinsons Disease Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Parkinsons Disease Market - Industry Life Cycle |
3.4 Austria Parkinsons Disease Market - Porter's Five Forces |
3.5 Austria Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Austria Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Austria Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Austria Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Austria Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Austria Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Austria |
4.2.2 Technological advancements in diagnosis and treatment of Parkinson's disease |
4.2.3 Growing awareness and focus on research and development in the healthcare sector |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatment |
4.3.2 Limited access to specialized healthcare services for Parkinson's disease patients |
4.3.3 Stringent regulatory requirements for approval of new treatments |
5 Austria Parkinsons Disease Market Trends |
6 Austria Parkinsons Disease Market, By Types |
6.1 Austria Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Austria Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Austria Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Austria Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Austria Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Austria Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Austria Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Austria Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Austria Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Austria Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Austria Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Austria Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Austria Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Austria Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Austria Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Austria Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Austria Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Austria Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Austria Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Austria Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Austria Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Austria Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Austria Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Austria Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Austria Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Austria Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Austria Parkinsons Disease Market Export to Major Countries |
7.2 Austria Parkinsons Disease Market Imports from Major Countries |
8 Austria Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of onset of Parkinson's disease in Austria |
8.2 Number of clinical trials for Parkinson's disease therapies in Austria |
8.3 Percentage of Parkinson's disease patients using advanced treatment options |
9 Austria Parkinsons Disease Market - Opportunity Assessment |
9.1 Austria Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Austria Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Austria Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Austria Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Austria Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Austria Parkinsons Disease Market - Competitive Landscape |
10.1 Austria Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Austria Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here